Article thumbnail
Location of Repository

Refinement and prediction of protein prenylation motifs

By Sebastian Maurer-Stroh and Frank Eisenhaber

Abstract

We refined the motifs for carboxy-terminal protein prenylation by analysis of known substrates for farnesyltransferase (FT), geranylgeranyltransferase I (GGT1) and geranylgeranyltransferase II (GGT2). In addition to the CaaX box for the first two enzymes, we identify a preceding linker region that appears constrained in physicochemical properties, requiring small or flexible, preferably hydrophilic, amino acids. Predictors were constructed on the basis of sequence and physical property profiles, including interpositional correlations, and are available as the Prenylation Prediction Suite (PrePS, ) which also allows evaluation of evolutionary motif conservation. PrePS can predict partially overlapping substrate specificities, which is of medical importance in the case of understanding cellular action of FT inhibitors as anticancer and anti-parasite agents

Topics: Software
Publisher: BioMed Central
Year: 2005
DOI identifier: 10.1186/gb-2005-6-6-r55
OAI identifier: oai:pubmedcentral.nih.gov:1175975
Provided by: PubMed Central

Suggested articles

Citations

  1. (1994). A prenylation motif is required for plasma membrane localization and biochemical function of casein kinase I in budding yeast.
  2. (1976). A simplified representation of protein conformations for rapid simulation of protein folding.
  3. (2001). Actin' up: RhoB in cancer and apoptosis. Nat Rev Cancer
  4. (2001). Alessi DR: Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/ STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth.
  5. (2004). Alexandrov K: Structure of the Rab7:REP-1 complex: insights into the mechanism of Rab prenylation and choroideremia disease. Cell
  6. (1997). AM: Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo.
  7. (1988). Amino acid side chain parameters for correlation studies in biology and pharmacology.
  8. (1996). Analysis of amino acid indices and mutation matrices for sequence comparison and structure prediction of proteins. Protein Eng
  9. (1979). Antiparallel and parallel beta-strands differ in amino acid residue preferences. Nature
  10. (2002). Bairoch A: The PROSITE database, its status in 2002. Nucleic Acids Res
  11. (1997). Better prediction of protein cellular localization sites with the k nearest neighbors classifier.
  12. (2000). C: Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins.
  13. (1998). Canet E, Fauchere JL: Chromatographic assay and peptide substrate characterization of partially purified farnesyl- and geranylgeranyltransferases from rat brain cytosol. Arch Biochem Biophys
  14. (1998). Celis JE: Rab11a is modified in vivo by isoprenoid geranylgeranyl. Electrophoresis
  15. (1994). Consequences of altered isoprenylation targets on a-factor export and bioactivity.
  16. (2003). Der CJ: Opinion: Searching for the elusive targets of farnesyltransferase inhibitors. Nat Rev Cancer
  17. (2003). DF: Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics. Mol Biochem Parasitol
  18. (1997). DG: The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res
  19. (2003). Eisenhaber F: Motif refinement of the peroxisomal targeting signal 1 and evaluation of taxon-specific differences.
  20. (2004). Eisenhaber F: MYRbase: analysis of genome-wide glycine myristoylation enlarges the functional spectrum of eukaryotic myristoylated proteins. Genome Biol
  21. (2002). Eisenhaber F: N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence.
  22. (2002). Eisenhaber F: N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.
  23. (2003). Eisenhaber F: Prediction of peroxisomal targeting signal 1 containing proteins from amino acid sequence.
  24. (1999). Eisenhaber F: Prediction of potential GPImodification sites in proprotein sequences.
  25. (2003). Eisenhaber F: Protein prenyltransferases: anchor size, pseudogenes and parasites. Biol Chem
  26. (2003). Eisenhaber F: Protein prenyltransferases. Genome Biol
  27. (1998). Eisenhaber F: Sequence properties of GPIanchored proteins near the omega-site: constraints for the polypeptide binding site of the putative transamidase. Protein Eng
  28. (1998). Erdmann R: Pex19p, a farnesylated protein essential for peroxisome biogenesis. Mol Cell Biol
  29. (2003). et al.: Structure of rab escort protein-1 in complex with rab geranylgeranyltransferase. Mol Cell
  30. (2003). et al.: The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res
  31. (2000). Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies. Oncogene
  32. (1995). Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21 transformation. Oncogene
  33. (1999). Fauchere JL: Investigation of S-farnesyl transferase substrate specificity with combinatorial tetrapeptide libraries. Cell Signal
  34. (2001). Grishin NV: AL2CO: calculation of positional conservation in a protein sequence alignment. Bioinformatics
  35. (2001). Hume AN, Seabra MC: Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease.
  36. (1991). JB: Sequence dependence of protein isoprenylation.
  37. (2003). Jr: Protein prenylation: a pivotal posttranslational process.
  38. (1979). Komoriya A: Local interactions as a structure determinant for protein molecules: II. Biochim Biophys Acta
  39. (1999). Kuznetsov EN: PSIC: profile extraction from sequence alignments with position-specific counts of independent observations. Protein Eng
  40. (1997). Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res
  41. (2004). LS: Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
  42. (2003). LS: Structure of mammalian protein geranylgeranyltransferase type-I.
  43. (2000). LS: The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures. Structure Fold Des
  44. (1998). Maltese WA: Prenylation of Rab8 GTPase by type I and type II geranylgeranyl transferases.
  45. (1987). MJ: Prediction of protein secondary structure and active sites using the alignment of homologous sequences.
  46. (1994). MS: Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase. Biochim Biophys Acta
  47. (2003). Nagata K: Involvement of nucleocytoplasmic shuttling of yeast Nap1 in mitotic progression. Mol Cell Biol
  48. (2002). Ouzounis CA: An efficient algorithm for large-scale detection of protein families.
  49. (1997). Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis
  50. (1985). Prediction of chain flexibility in proteins. A tool for the selection of peptide antigens. Naturwiss
  51. (2003). Prediction of lipid posttranslational modifications and localization signals from protein sequences: big-Pi, NMT and PTS1. Nucleic Acids Res
  52. Prediction of posttranslational modifications from amino acid sequence: problems, pitfalls, methodological hints.
  53. (2004). Prediction of sequence signals for lipid post-translational modifications: insights from case studies. Proteomics
  54. (2003). Preferential binding of the histone (H3-H4)2 tetramer by NAP1 is mediated by the amino-terminal histone tails.
  55. Prenylation Prediction Suite [http://mendel.imp.uni vie.ac.at/sat/PrePS]
  56. (1998). Profile hidden Markov models. Bioinformatics
  57. (2001). Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells. Cell Mol Life Sci
  58. (1991). Ptitsyn OB: Physical reasons for secondary structure stability: alpha-helices in short peptides. Proteins
  59. (1998). Role of the carboxyterminal residue in peptide binding to protein farnesyltransferase and protein geranylgeranyltransferase. Arch Biochem Biophys
  60. (1978). Scheraga HA: Influence of water on protein structure. An analysis of the preferences of amino acid residues for the inside or outside and for specific conformations in a protein molecule. Macromolecules
  61. (2002). Scoring residue conservation. Proteins
  62. (2004). SE: WebLogo: a sequence logo generator. Genome Res
  63. (2001). Seabra MC: Evolution of the Rab family of small GTP-binding proteins.
  64. (2003). Seabra MC: Membrane targeting of Rab GTPases is influenced by the prenylation motif. Mol Biol Cell
  65. (2005). Siminovitch KA: Molecular characterization of hNRP, a cDNA encoding a human nucleosome-assembly-protein-I-related gene product involved in the induction of cell
  66. (1982). Structural prediction of membrane-bound proteins.
  67. (1987). Sugino Y: Dependence of conformational stability on hydrophobicity of the amino acid residue in a series of variant proteins substituted at a unique position of tryptophan synthase alpha subunit. Proc Natl Acad Sci USA
  68. (2000). The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily.
  69. (1976). The nature of the accessible and buried surfaces in proteins.
  70. (2002). The yeast DHHC cysteinerich domain protein Akr1p is a palmitoyl transferase.
  71. (1994). Torkkila E, Riikonen P: Accuracy of protein flexibility predictions. Proteins
  72. (2004). UniProt: the Universal Protein knowledgebase. Nucleic Acids Res
  73. Valid CaaX tetrapeptides at the PrePS site [http://men del.imp.univie.ac.at/sat/PrePS/tetraTable.html]
  74. (2004). WR: Farnesyltransferase inhibitors as anticancer agents: critical crossroads. Curr Opin Drug Discov Devel
  75. (2004). Y: A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proc Natl Acad Sci USA
  76. (1993). Zahraoui A: Isoprenylation of Rab proteins possessing a C-terminal CaaX motif. FEBS Lett

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.